Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/3037
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNewton, DL-
dc.contributor.authorPollock, D-
dc.contributor.authorDiTullio, P-
dc.contributor.authorEchelard, Y-
dc.contributor.authorHarvey, M-
dc.contributor.authorWilburn, B-
dc.contributor.authorWilliams, J-
dc.contributor.authorHoogenboom, HR-
dc.contributor.authorRAUS, Jef-
dc.contributor.authorMeade, H. M.-
dc.contributor.authorRybak, SM-
dc.date.accessioned2007-11-23T13:51:49Z-
dc.date.available2007-11-23T13:51:49Z-
dc.date.issued1999-
dc.identifier.citationJOURNAL OF IMMUNOLOGICAL METHODS, 231(1-2). p. 159-167-
dc.identifier.issn0022-1759-
dc.identifier.urihttp://hdl.handle.net/1942/3037-
dc.description.abstractAntibodies fused to human enzymes offer an alternative to specifically targeting tumors with antibodies linked to plant or bacterial toxins. Since large amounts of these reagents can be administered without eliciting non-specific toxicities, efficient methods of production are needed. The goal of this work was to express a complex immunoenzyme fusion protein (immunotoxin) in the mammary gland of transgenic mice. A chimeric mouse/human antibody directed against the human transferrin receptor (E6) was fused at its CH2 domain to the gene for a human angiogenic ribonuclease, angiogenin (Ang). It was expressed in the mammary gland of mice and secreted into mouse milk. Expression levels in milk were approximately 0.8 g/l. The chimeric protein retained antibody binding activity and protein synthesis inhibitory activity equivalent to that of free Ang. It was specifically cytotoxic to human tumor cells in vitro. (C) 1999 Elsevier Science B.V. All rights reserved.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE BV-
dc.subject.othertransgenic mice; ribonuclease; immunotoxin; antitransferrin receptor antibody-
dc.titleAntitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice-
dc.typeJournal Contribution-
dc.identifier.epage167-
dc.identifier.issue1-2-
dc.identifier.spage159-
dc.identifier.volume231-
local.format.pages9-
dc.description.notesNCI, Pharmacol Expt Therapeut Sect, Lab Drug Discovery Res & Dev,Dev Therapeut Program, Div Canc Treatment & Diag,Frederick Canc Res & De, Frederick, MD 21702 USA. NCI, Intramural Res Support Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA. Genzyme Transgen, Framingham, MA 01701 USA. Maastricht Univ, Dept Pathol, CESAME, NL-6202 AZ Maastricht, Netherlands. DL Willems Inst, B-3590 Diepenbeek, Belgium.Rybak, SM, NCI, Pharmacol Expt Therapeut Sect, Lab Drug Discovery Res & Dev,Dev Therapeut Program, Div Canc Treatment & Diag,Frederick Canc Res & De, Bldg 567,Room 152, Frederick, MD 21702 USA.-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/S0022-1759(99)00154-4-
dc.identifier.isi000085673800014-
item.fulltextNo Fulltext-
item.fullcitationNewton, DL; Pollock, D; DiTullio, P; Echelard, Y; Harvey, M; Wilburn, B; Williams, J; Hoogenboom, HR; RAUS, Jef; Meade, H. M. & Rybak, SM (1999) Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice. In: JOURNAL OF IMMUNOLOGICAL METHODS, 231(1-2). p. 159-167.-
item.contributorNewton, DL-
item.contributorPollock, D-
item.contributorDiTullio, P-
item.contributorEchelard, Y-
item.contributorHarvey, M-
item.contributorWilburn, B-
item.contributorWilliams, J-
item.contributorHoogenboom, HR-
item.contributorRAUS, Jef-
item.contributorMeade, H. M.-
item.contributorRybak, SM-
item.accessRightsClosed Access-
item.validationecoom 2001-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

29
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

27
checked on Jan 16, 2024

Page view(s)

84
checked on Nov 7, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.